WallStreetZenWallStreetZen

NASDAQ: PCRX
Pacira Biosciences Inc Stock Ownership - Who owns Pacira Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pacira Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Abraham CeesayDirector2025-09-042,354$27.19
$64.01kSell
Marcelo BigalDirector2025-08-074,912$23.67
$116.27kSell
Jonathan SloninChief Medical Officer2025-08-01315$22.07
$6.95kSell
Kristen WilliamsChief Administrative Officer2025-06-0414,376$26.24
$377.23kSell
Lauren RikerSenior Vice President Finance2025-06-045,578$26.21
$146.20kSell
Jonathan SloninChief Medical Officer2025-06-035,084$26.40
$134.22kSell
Kristen WilliamsChief Administrative Officer2025-06-036,162$26.40
$162.68kSell
Lauren RikerSenior Vice President Finance2025-06-033,374$26.40
$89.07kSell
Jonathan SloninChief Medical Officer2025-01-06879$18.40
$16.17kSell
Frank D. LeeChief Executive Officer2025-01-029,375$18.33
$171.84kSell

1 of 2

PCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCRX insiders and whales buy or sell their stock.

PCRX Shareholders

What type of owners hold Pacira Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc17.35%7,796,029$166.68MInstitution
Vanguard Group Inc12.03%5,405,964$115.58MInstitution
Orbimed Advisors LLC11.74%5,274,941$112.78MInsider
Andreas Wicki9.09%4,085,359$87.34MInsider
Carl L. Gordon6.30%2,828,941$60.48MInsider
Mpm Bioventures IV Qp LP6.21%2,790,479$59.66MInsider
Vaughn M. Kailian6.21%2,790,479$59.66MInsider
Renaissance Technologies LLC5.33%2,395,601$51.22MInstitution
D E Shaw Co Inc5.01%2,253,365$48.18MInstitution
Hbm Healthcare Investments Cayman Ltd4.97%2,233,993$47.76MInsider

1 of 3

PCRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCRX68.66%31.34%Net SellingNet Selling
CRON12.30%48.73%Net Selling
COLL51.08%48.92%Net SellingNet Selling
AMPH48.28%51.72%Net BuyingNet Selling
DVAX63.58%36.42%Net SellingNet Selling
View Top Pharmaceutical Stocks

Pacira Biosciences Stock Ownership FAQ

Who owns Pacira Biosciences?

Pacira Biosciences (NASDAQ: PCRX) is owned by 112.49% institutional shareholders, 51.34% Pacira Biosciences insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Pacira Biosciences shareholder, owning 5.27M shares representing 11.74% of the company. Orbimed Advisors LLC's Pacira Biosciences shares are currently valued at $112.78M.

If you're new to stock investing, here's how to buy Pacira Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.